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Outcomes of endovascular treatment of chronic
total occlusion of the infrarenal aorta
Tae-Hoon Kim, MD,a Young-Guk Ko, MD,a Ung Kim, MD,b Jung-Sun Kim, MD, PhD,a Donghoon
Choi, MD, PhD,a Myeong-Ki Hong, MD, PhD,a Yangsoo Jang, MD, PhD,a and Won-Heum Shim, MD,
PhD,a Seoul and Pusan, South Korea
Background: Few reports have been published on the outcomes of endovascular therapy in chronic total occlusion of the
aorta.
Methods: Endovascular treatment was attempted in 49 patients (40 men and nine women; aged 64.1  10.9 years) with
infrarenal aortic occlusion between January 1995 and December 2009. The first attempt at wire passage and balloon
angioplasty was usually performed by an antegrade approach through the brachial artery. Stents were implanted with or
without intra-arterial administration of thrombolytic agents. We investigated the immediate and midterm outcomes of
endovascular therapy for chronic infrarenal aortic occlusions.
Results:Technical success was achieved in 40 patients (81.6%). Procedural failures were due to wire passage failure in eight
patients and to embolization and spinal cord infarction in one. Stents were implanted in 97.5% of patients. Major
complications occurred in eight patients (16.3%): two neurologic events (spinal and cerebral infarction), two cases of
jailed renal artery after stenting, and one case each of periprocedural death from pneumonia, distal embolization
requiring embolectomy, iliac artery rupture requiring implantation of covered stents, and access site pseudoaneurysm
treated with surgery. In patients treated successfully, the primary patency rate was 88.4% at 1 year and 80.1% at 3 years.
The major amputation rate was 0%. Seven patients (17.5%) required repeat intervention (n  5) or bypass surgery (n 
2) during the follow-up period.
Conclusion: Endovascular therapy of infrarenal aortic occlusion was feasible in most cases, and midterm patency was
favorable. However, because of relatively high procedurally related complication rates, cautious selection of patients and
appropriate preventive measures are necessary to improve immediate outcomes. (J Vasc Surg 2011;53:1542-9.)
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cTotal occlusion of the infrarenal aorta is a rare disease
with an estimated prevalence of 0.15%, according to an
autopsy study.1 Total occlusion of the infrarenal aorta has
been identified in 3% to 8.5% of patients presenting with
aortoiliac occlusive disease.2-4 Traditionally, surgical treat-
ments, such as bypass surgery and endarterectomy, have
been considered the standard treatment of aortoiliac occlu-
sive disease. The long-term surgical outcomes are favor-
able, and the reported cumulative patency rates are 76.6%
at 10 years and 67.5% at 20 years.5 However, surgical
treatments are generally associated with relatively high rates
of mortality and morbidity, longer hospitalization, and
delayed recovery.5-8
Therefore, endovascular therapy, a less invasive proce-
dure, presents an attractive alternative treatment for aortic
disease. Recent studies have shown improved clinical out-
comes of endovascular therapy in complex iliac lesions
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1542nvolving the aortic bifurcation due to recent advances in
evices and skills.9-15 However, there are a paucity of data
n immediate and long-term outcomes of endovascular
reatments of chronic aortic occlusive disease.16,17 We
herefore sought to investigate the immediate and long-
erm outcomes of endovascular therapy in patients with
hronic total occlusion of the infrarenal aorta.
ATERIAL AND METHODS
The Institutional Review Board of Severance Hospital,
onsei University Health System approved this study and
aived the requirement for informed consent for this ret-
ospective analysis.
Patient population. This was a single-center, retro-
pective, observational study that included 49 patients (40
en, nine women) who were a mean  SD age of 64.1 
0.9 years (range, 36-86 years). Patients had chronic total
cclusion of the infrarenal aorta, and endovascular treat-
ent was attempted between January 1995 and Decem-
er 2009 at Severance Cardiovascular Hospital, Seoul,
orea. Our indication for endovascular therapy was
oderate-to-severe claudication or critical limb ischemia
ith age 75 years (16.3%), severe chronic obstructive
ulmonary disease (14.3%), heart failure defined as ejec-
ion fraction 40% (20.4%), coronary artery disease
49.0%), previous stroke (14.3%), or refusal for open
urgery (28.6%). Patients with sudden onset of symp-
oms related to aortic occlusion 2 months of the pro-
edure or aortic occlusion caused by thromboembolism
ere excluded.
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Volume 53, Number 6 Kim et al 1543Before therapeutic angiography, all patients under-
went a physical evaluation; a noninvasive hemodynamic
evaluation, including ankle-brachial index (ABI), seg-
mental pressures, and pulse volume recordings; and at
least one imaging study, including computed tomogra-
phy (CT) or magnetic resonance angiography.
CT imaging. Preprocedural CT imaging was per-
formed in all enrolled patients. However, CT images of
only 34 patients were available for detailed analysis. Cal-
cium deposits were defined as structures within the vessel
wall with an attenuation130 HU that were hyperattenu-
ated compared with contrast-enhanced lumen and sur-
rounding parenchyma. The differences between the calcifi-
cation density and the lumen or noncalcified aortic wall
were recognizable through the precontrast images with
wide, fixed window settings (700 HU window, 250 HU
level) in most cases; however, several patients required
changes in the level and windows for optimal visualization
(range, 600-1000 HU window; 150-400 HU level). The
extent of aortic wall calcium was measured by summation
of arcs of aortic calcification at the cross-sectional level of
most calcified aorta within the occluded segment.
Endovascular therapy. All procedures were per-
formed under local anesthesia supplemented with intra-
venous sedation and analgesia when required. Patients
received a combination of aspirin (100 mg/d) and clopi-
dogrel (75 mg/d) or ticlopidine (500 mg/d) at least 3
days before the procedure. Systemic heparin (5000 IU)
was administered to achieve an activated clotting time
200 seconds.
For the treatment of occlusive infrarenal aortic lesions,
with or without involvement of the iliac arteries, a com-
bined antegrade and retrograde approach from the brachial
and femoral arteries was used in 40 patients (81.6%). A 7F
Shuttle Sheath (Cook, Bloomington, Ind) was inserted
through the left brachial artery, and the tip of the Shuttle
Sheath was placed above the proximal stump of the aortic
occlusion. Additional vascular access was gained into the
bilateral common femoral arteries. The initial attempt at
crossing the occlusion was generally made with a 0.035-
inch hydrophilic guidewire (angled or straight tip, Terumo,
Tokyo, Japan) by an antegrade approach from above the
lesion. If the wire passage failed by the antegrade approach,
a retrograde approach from femoral arteries was tried for
the wire crossing.
When wires were successfully passed from the brachial
sheath to iliac arteries, they were grasped with a snare
inserted from the common femoral arteries. Then, the
procedure was done from the femoral arteries. In nine other
patients (18.4%), a retrograde approach only was attempted
from both femoral arteries. All femoral and brachial access
sites were prepared percutaneously using a vascular sheath.
None of the patients required a surgical cutdown.
After successful wire passage, the occlusive lesion was
predilated with an undersized balloon in all patients. There-
after, a balloon-expandable or a self-expandable stent was
deployed according to the operator’s decision. Self-
expandable stents were generally preferred in lesions with a darge thrombotic burden, whereas balloon-expandable
tents were more favored in calcified lesions. If an occlusive
esion was confined to the infrarenal aorta, single large
ortic stents (diameter, 20-26 mm) were implanted. In
ases of aortic occlusion with common iliac artery involve-
ent, a kissing-stent method deploying two stents (diam-
ter, 8-14 mm) in the bilateral common iliac arteries and
orta, with simultaneous balloon dilation, was performed.
If occlusive lesions extensively involved the infrarenal
orta and iliac arteries, a combined stenting method of an
ortic stent and two aortoiliac kissing stents was performed.
he kissing stents and larger aortic stents were delivered
hrough the femoral arteries. If an aortic stent and two
issing stents were required, the aortic stent was placed first
nd then the two iliac stents were implanted in overlap with
he aortic stent.
After implantation of stents, with or without adjuvant
alloon dilation, the pressure gradient over the treated
esion was measured by simultaneous recording of the
ean systolic pressures proximal to and distal of the treated
esion. If there was significant residual stenosis (30%),
ow-limiting dissection, or a pressure gradient 20 mm
g, additional balloon dilation or stent implantation was
erformed. Angiography was performed to document the
nal results and to detect distal embolization or vessel
erforation.
Patients with multiple visible mobile thrombi or
istal embolization after predilation or stent implanta-
ion were considered to have large thrombotic burden.
n such patients, urokinase was administered by catheter
s a bolus (100,000-200,000 IU) or continuous infu-
ion (60,000-100,000 IU/h for 4 to 24 hours) after
he first balloon predilation or after the procedure, at the
perator’s discretion. After successful recanalization, all
atients received a combination of aspirin (100 mg/d),
lopidogrel (75 mg/d), ticlopidine (500 mg/d), or
ilostazol (200 mg/d) for at least 1 year.
After discharge, patients were evaluated as regular clin-
cal follow-up at 3-month intervals for 1 year and then at
-month intervals thereafter. A representative case of endo-
ascular therapy for chronic occlusion of infrarenal aorta is
hown in Fig 1.
Follow-up. All patients who underwent technically
uccessful procedures were clinically monitored at 1 month
nd every 3 months thereafter. Noninvasive hemodynamic
valuations, including ABI, segmental pressures, and pulse
olume recordings were performed before discharge from
he hospital and every 6 months thereafter or in cases of
ymptom deterioration. Follow-up CT angiography or
valuation with color duplex ultrasound imaging was per-
ormed 1 month after the procedure and every year
hereafter or in cases of symptom deterioration. Follow-up
ngiography was performed if any symptoms worsened by
ne Rutherford category, the ABI decreased by 0.15 on
ulse volume recording, or restenosis of50% was seen on
noninvasive imaging study such as CT angiography or
uplex ultrasound imaging.
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June 20111544 Kim et alDefinitions and statistical analysis. Technical suc-
cess was defined as successful recanalization of a totally
occluded aorta and both iliac arteries without any flow
limitation on final angiography. A complication was de-
fined as major if it led to therapeutic reintervention, perma-
nent morbidity, or death. Acute renal failure was defined as
a 50% increase in serum creatinine, with a creatinine level of
at least 2.0 mg/dL. Loss of patency was defined as both a
drop in the ABI by 0.15 and a luminal narrowing on CT
or angiography by50%.18 A significant (50%) restenosis
was also diagnosed using duplex ultrasound imaging if a
peak velocity 300 cm/s or a lesion velocity/adjacent
segment velocity ratio of 3.5 was present.
Primary patency was that achieved after the initial pro-
cedure only. A failure of primary patency was defined as
reocclusion or the need for an additional percutaneous
procedure. Secondary patency was defined as that achieved
after one or more successful additional percutaneous pro-
cedures within the stent or balloon angioplasty site or at its
margins.19
Odds ratios (ORs) and 95% confidence intervals (CIs)
were calculated with univariate logistic regression to corre-
late patient and angiographic or CT parameters with pro-
cedural failure. Age, gender, and variables with a P value
.2 in the univariate model were entered into a multivariate
logistic regressionmodel to calculate independent effects of
Fig 1. A representative case of endovascular therapy
infrarenal aorta. A, The initial angiography shows a tota
inserted into the totally occluded aorta by the subintimal a
left common femoral artery.D, Adjuvant ballooning is a
mm [S & G, Korea]). E, Adjuvant kissing ballooning is a
 150mm [TaewongMedical, Korea] at each side). F,Th
and iliac arteries.patient and procedural characteristics on procedural failure. (ategoric binary logistic analysis was used to compare the
echnical success rates of the three periods. The primary and
econdary patency rates during follow-up were displayed
ith Kaplan-Meier event-free survival curves. A value of
 .05 was considered statistically significant. All statistical
ests were performed with SPSS 18.0 software (SPSS Inc,
hicago, Ill).
ESULTS
Patients. Baseline clinical characteristics of the pa-
ients are presented in Table I. Of the 49 enrolled patients,
8 (57.1%) were treated between 2005 and 2009, and nine
18.4%) were treated before 2000. The cohort consisted of
1 men (81.9%), and 36 patients (73.5%) were former or
urrent smokers. All patients were symptomatic. The most
ommon symptom in enrolled patients was claudication of
he buttocks or thighs in 40 (81.6%), followed by resting
ain in six (12.2%), and minor tissue loss in three (6.1%).
he mean preprocedural ABI was 0.39  0.18 in the right
imb and 0.40  0.19 in the left limb.
Preprocedural coronary angiography was performed in
ll patients and showed significant coronary artery disease
n 24 (49.0%). The site of proximal occlusion of the aorta
as classified according to the level of patent vessels by
ngiogram at the time of intervention, which showed that
he juxtarenal artery was the site of occlusion in 24 patients
combined aortoiliac stenting for chronic occlusion of
cluded aorta below the renal arteries, B, A guidewire is
ach.C,The guidewire is captured by a snare through the
d at the deployed single aortic stent (Hercules 24 60
ed over the deployed two kissing stents (Niti-S stents, 8
al angiogram shows no residual stenosis both in the aortawith
lly oc
ppro
chieve
chiev
e fin60.0%), followed by below the inferior mesenteric artery in
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Volume 53, Number 6 Kim et al 154513 (26.5%), and above the aortic bifurcation in seven
(14.3%). Both renal arteries were patent before the proce-
dure in all but two patients.
Procedural results. Procedural data of endovascular
treatment are presented in Table II. Technical success was
achieved in 40 patients (81.6%). There were nine cases of
procedural failure. Procedural failures were due to failure of
wire passage in eight patients (88.9%). However, one fail-
ure was due to incompletion of the procedure due to distal
embolization and spinal cord infarction.
Among the 40 patients with successful recanalization of
the aorta, 37 (92.5%) were treated with stent implantation
in the infrarenal aorta, two patients (5.0%) were treated
with stent implantation confined to the common iliac ar-
teries, and one patient (2.5%) was treated with balloon
angioplasty alone. The most frequently used stenting tech-
nique was the kissing-stent method (56.4%), followed by
the combined method of a single aorta stent and two
kissing stents (23.1%), and single aorta stent (15.4%). Of
the 39 patients treated with stent implantation, 16 (41%)
required additional stenting in a diseased external iliac
artery. Self-expandable stents were used in 91.4% patients,
and balloon-expandable stents were used in 8.6%.
Intra-arterial urokinase was administered during or af-
ter the procedure in 21 of 49 patients (42.8%). The mean
duration of the urokinase infusion was 15.5  17.8 hours
(range, 4-72 hours). Patients with technical success showed
nearly normalized postoperative ABI (0.93  0.20 in the
Table I. Baseline clinical characteristics of the study
population
Characteristics
Mean  SD
No. (%)
Patients 49
Age, years 64.1  10.9
Male sex 40 (81.9)
Medical history
Cerebrovascular accident 7 (14.3)
Coronary artery disease 24 (49.0)
Diabetes mellitus 15 (30.6)
Hypertension 30 (61.2)
Smoking 36 (73.5)
Hypercholesterolemia 24 (49.0)
Heart failure (LVEF 40%) 10 (20.4)
Takayasu arteritis 2 (4.1)
Chronic renal insufficiency 7 (14.3)
Malignancy 1 (2.0)
Rutherford category
2, moderate claudication 7 (14.3)
3, severe claudication 33 (67.3)
4, ischemic rest pain 6 (12.2)
5, minor tissue lossa 3 (6.1)
Pre-op ABI
Right 0.39  0.18
Left 0.40  0.19
ABI, Ankle-brachial index; LEVF, left ventricular ejection fraction; SD,
standard deviation.
aDefined as ischemic ulcer or gangrene.right limb, and 0.93  0.15 in the left limb). aAdverse events and in-hospital course. The median
ength of hospitalization was 8.5 days (range, 3-35 days).
ajor complications occurred in eight patients (16.3%).
ne (2.0%) periprocedural death caused by pneumonia-
elated sepsis occurred in a 68-year-old man with diabetes
nd chronic renal failure. A spinal cord infarction with distal
mbolization occurred in one patient after deployment of
he aortic stents. Cerebral infarction was documented in
ne patient. There were two patients with jailed renal
rteries after stent implantation and one patient with com-
on iliac artery rupture after balloon dilation, which were
romptly managed by endovascular treatment without
ausing hemodynamic instability. One patient with acute
istal embolization was treated with catheter-based embo-
ectomy. One other patient with access-site pseudoaneu-
ysm at the common femoral artery required surgical repair.
Acute renal failure developed in three patients (6.1%)
fter the procedure; however, baseline creatinine levels
ecovered in all patients after conservative management
lone. Four patients presented with distal embolization-
imiting blood flow for an overall rate of 8.2%. Distal
mbolization-limiting blood flow was identified as a distal
lling defect with an abrupt cutoff or slowed distal blood
ow.
Distal blood flow in two patients was restored by intra-
rterial infusion of urokinase. One was treated with catheter-
ased embolectomy. Embolization in another caused spinal
ord infarction and incompletion of the procedure, as was
escribed. The overall rate of vascular complications was
4.3% (n 7): an access site hematoma3 cm was seen in
hree patients (two femoral arteries and one brachial ar-
ery), and pseudoaneurysms were documented in two pa-
ients (Table III). Only one patient required surgical repair.
n addition, asymptomatic brachial artery occlusion was
oted in two patients later during follow-up. Neither re-
uired surgical or endovascular treatment.
Factors associated with technical failure. To evalu-
te the effect of operator experience and the availability of
arious endovascular devices, we compared technical suc-
ess rates from different periods at 5-year intervals: January
995 to December 1999 was defined as period 1, January
000 toDecember 2004was period 2, and January 2005 to
ecember 2009 was period 3. Period 3 showed a success
ate similar to those of periods 1 (P  .5) and 2 (P  .73).
e also investigated the extent of aortic calcification that
ight be associated with technical failure in 34 patients
hose preprocedural CT images were available for detailed
nalysis.
Univariate analysis, including clinical variables (ie, age,
ender, coronary artery disease, diabetes mellitus, hyper-
ension, smoking, dyslipidemia, and preprocedural renal
nsufficiency), the extent of aortic calcification on cross-
ectional CT images, the level of proximal occlusion site,
nd length of the occluded lesion showed that only severe
ortic calcification was associated with increased risk of
echnical failure (OR, 6.252; 95% CI, 1.543-25.335; P 
010). The occlusion length, measured from the proximal
ortic occlusion site to the longest distal iliac occlusion site,
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June 20111546 Kim et alalso showed a trend toward increased risk of technical
failure (OR, 1.006; 95% CI, .997-1.016; P  .181). A
multivariate analysis using the two variables of extent of
aortic calcification and length of occlusion and demon-
strated that only the severity of aortic calcification was an
independent risk factor of technical failure (OR, 6.235;
95% CI, 1.507-25.788; P  .012; Table IV).
Follow-up. Patients with technical success were mon-
itored for amedian duration of 41.9 42.2months (range,
3 days-13 years). During the follow-up, seven patients
(17.5%) underwent repeat angioplasty (n  5) or bypass
surgery (n  2) due to reocclusion. All second procedures
Table II. Procedural results of endovascular treatment
Procedural results Patie
Procedural success 40
Procedural failure 9
Procedural approach
Combined,a brachial and femoral arteries 40
Retrograde, from femoral arteries 9
Procedural method
Balloon dilatation without stent 1
Stent implantation 39
Administration of urokinase 21/49
Stent techniques
Single aortic stent 6
Kissing stents 22
Combined stentsb 9
Aortic stent
Kissing stents
Iliac stent without aortic stent 2
Sten
Deployed stents
Self-expandable stents 96
Balloon-expandable stents 9
aAntegrade and retrograde approach.
bCombined stents: single stent with kissing stents.
Table III. Procedural complications and in-hospital
events
Complications Pts (%)
Major complication 8 (16.3)
In-hospital death 1 (2.0)
Spinal cord infarction with distal embolization 1 (2.0)
Cerebral infarction 1 (2.0)
Rupture of iliac artery 1 (2.0)
Distal embolism requiring embolectomy 1 (2.0)
Jailed renal artery by stent 2 (4.1)
Access-site pseudoaneurysm requiring operation 1 (2.0)
Acute distal embolism 4 (8.2)
Acute renal failure 3 (6.1)
Vascular complication 5 (14.3)
Large hematoma (3 cm) 3 (6.1)
Pseudoaneurysm 2 (4.1)
Brachial artery occlusion 2 (4.1)were performed successfully. Including technical failures, whe primary patency rate was 70.3% at 1 year and 63.7% at 3
ears, and the secondary patency was 76.7% at 1 year and
3.3% at 3 years (Fig 2, A). In patients treated successfully,
he primary patency was 88.4% at 1 year and 80.1% at 3
ears, and the secondary patency rate was 96.4% at 1 year
nd 92.0% at 3 years (Fig 2, B).
The all-cause mortality rate was 2.0% at 1 year and 4.1%
t 3 years. One patient died of pneumonia-related sepsis in
he periprocedural period and another patient died of isch-
mic cardiomyopathy at 2 years. Themajor amputation rate
as 0%. Only one patient required minor amputation of a
oe, despite repeated angioplasty of the external iliac artery
ue to restenosis.
ISCUSSION
Our experience demonstrated that percutaneous revas-
ularization of the chronically occluded infrarenal aorta was
easible in 81.9% of patients. However, recanalization of
he occluded aorta was not infrequently associated with
dverse events, such as neurologic events, distal emboliza-
ion, side branch jailing, access site vascular complications,
nd acute renal failure. Despite these acute events, most of
he complications were successfully managed with minor
nterventions or conservative treatment. In patients with
echnical success, the primary and secondary patency rates
f the recanalized aorta were favorable over 3 years.
Chronic total occlusion of abdominal aorta is a rare
isease. Traditionally, surgical therapy has been the treat-
ent of choice. Surgical treatment such as aortobifemoral
ypass grafting is generally known to have durable results,
6)
4)
6)
4)
)
5)
8)
Diameters (mm) Lengths (mm)
Mean  SD Mean  SD
4) 29.3  7.6 53.3  30.6
4) 11.2  2.2 75.5  16.3
1)
22.0  3.3 58.9  3.3
8.7  1.8 90.0  28.3
) 10.0  2.3 70.0  28.3
4)
)nts, %
(81.
(18.
(81.
(18.
(2.5
(97.
(42.
(15.
(56.
(23.
(5.1
ts (%)
(91.
(8.6ith 5-year patency rates of approximately 80% to 85%.20
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Volume 53, Number 6 Kim et al 1547However, surgical treatment is associated with significant
perioperative mortality and morbidity, including sexual
dysfunction, ureteral damage, intestinal ischemia, and spi-
nal cord injury. A previous meta-analysis found a mortality
Table IV. Univariate and multivariate logistic regression a
Variable OR 95% CI
Characteristics
Age 1.031 0.961-1.106
Male gender 2.000 0.218-18.388
CADa 0.800 0.187-3.423
Diabetesb 1.167 0.250-5.453
Hypertension 0.750 0.174-3.237
Smoking 1.328 0.238-7.398
Dyslipidemia 0.452 0.099-2.065
Renal insufficiency 2.000 0.321-12.463
Extents of calcium on CT 6.252 1.543-25.335
Angiographic variables
Occlusion length (mm) 1.006 0.997-1.016
Proximal occlusion site
Juxtarenal 1.920 0.287-12.862
Infrainferior mesenteric 0.873 0.146-5.219
Aortic bifurcation
Procedure periods
1995-1999 (period I) 0.458 0.048-4.420
2000-2004 (period II) 0.733 0.125-4.289
2005-2009 (period III)
CAD, Coronary artery disease; CI, confidence interval; CT, computed tom
aDefined as 50% luminal narrowing in any major coronary artery.
bPatients who had fasting glucose 126 or were taking oral hypoglycemic m
cStandard, a standard site or period to compare the failure rate according to
Fig 2. Kaplan-Meier curves of primary and secondary p
(B) patients whose endovascular therapy was successful.rate of 3.3% to 4.6% and morbidity of 8.3% to 13.1%.20 surgical therapy is also generally associated with delayed
ecovery and prolonged hospitalization.
So far, only a limited number of studies have reported
he outcomes of endovascular therapy for stenotic or occlu-
is for predictors of technical failure
P
nivariable OR 95% CI
P
Multivariable
.396
.540
.764
.845
.700
.746
.306
.458
.010 6.235 1.507-25.788 .012
.181 1.005 0.994-1.017 .383
.501
.881
Standardc
.500
.731
Standard
y; OR, odds ratio.
tion.
ites or different time periods.
y for all patients (A) including technical failures and fornalys
U
ographatencive disease of the infrarenal aorta. Earlier studies, which
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June 20111548 Kim et alincluded mostly patients with stenotic lesions rather than
occlusive aortic disease, reported relatively high patency
rates of 75% to 89% at 3 to 5 years,21-24 which are compa-
rable with those of surgical treatments.5,25,26 Two recent
studies reported the outcomes of endovascular therapy in
study populations that exclusively included patients with
chronic total occlusion of the infrarenal aorta.
Krankenberg et al17 performed endovascular recon-
struction of the aortic bifurcation in 11 patients with
Leriche syndrome. Bilateral endovascular success was
achieved only in eight patients (73%), whereas unilateral
recanalization was feasible in three. The only procedur-
ally related complication was one acute thrombotic aor-
toiliac occlusion. During a median follow-up of 14
months, restenosis was observed in two patients.
Moise et al16 performed endovascular recanalization of
the aorta in 31 patients. Stenting of the aorta or common
iliac arteries was performed in 55% to 60% of the patients.
Technical success was achieved in 93%. There were no
deaths in the periprocedural period; however, various ma-
jor and minor procedurally related complications were ob-
served in approximately one-third of the treated patients.
The primary patency rate was 85% at 1 year and 66% at 3
years.16
Considering the procedural outcomes in the present
study and previous studies,16,17 the technical success rate of
endovascular therapy in chronic total occlusion of the in-
frarenal aorta ranges from 73% to 93% and seems to be
lower than rates reported for endovascular therapy of ste-
notic lesions or aortoiliac bypass surgery. The most com-
mon cause of technical failure was the failure to cross the
occluded lesion with the wire. We evaluated factors affect-
ing procedural success in this cohort. So far, there had been
no studies reporting the association between the extent of
aortic wall calcification and technical results of revascular-
ization in chronic total aortic occlusion. Previous studies
indicated that calcified stenoses were associated with a
decrease in success and an increase in the complication rate
of coronary intervention,27,28 and that the regional calcium
content on preprocedural multidimensional CT can be a
useful tool for predicting procedural failure in percutane-
ous coronary interventions of chronic total occlusion.29
Indeed, the results from the present study indicated that
severe aortic calcification was an independent determinant
of procedural failure.
There was also considerable prevalence of procedurally
related complications. Common complications were distal
embolization of thrombosis or plaque particles, perforation
of iliac arteries, vascular complications at the access site,
acute renal failure, and neurologic events, such as cerebral
or spinal cord infarction. Occluded aortoiliac lesions usually
have a larger burden of atherosclerotic plaque and throm-
bosis due to larger vessel size and longer lesion length
compared with other arterial systems. Several studies on
endovascular therapy of totally occluded iliac arteries also
demonstrated that the main procedurally related complica-
tions were embolic events, occurring with a prevalence of
4% to 24%, depending on the occlusion length.30-33 In thisespect, intra-arterial catheter-directed thrombolytic ther-
py may be helpful in preventing and treating thromboem-
olism. In the present study, thrombolytic agents were
dministered in 42.8% of the patients, and two of four
atients with acute distal embolization were treated suc-
essfully with thrombolytic therapy. However, vascular
omplications were also frequent due to use of thrombo-
ytic agents.
In this study, the primary patency in patients with
echnical success was maintained at 88.4% at 1 year and
0.1% at 3 years. These patency rates are higher than those
eported by Moise et al,16 which might be explained by the
ifferent frequencies of stent use. The aorta or iliac arteries
ere stented in 55% to 60% of the cases in the study by
oise et al, whereas 97.5% of patients in our study were
reated with stent implantation. Our experience suggests
hat the midterm patency rates of the percutaneously re-
analized and stented aorta are comparable to those of
ypass surgery.
Our study had several limitations. First, this was a
ingle-center retrospective observational study with a small
atient population. Second, there was variability in the
ethods of endovascular therapy among different opera-
ors and time periods. Further, the effects of improvement
n the operator’s skills and devices during the long study
eriod on the procedural outcomes could not be fully
valuated; however, a simple comparison of success rates
rom three different time periods showed no significant
ifference.
ONCLUSIONS
The midterm patency of endovascular treatment for
ortic total occlusive lesions was favorable. However, tech-
ical success needs to be improved, and procedurally re-
ated complications were relatively frequent. Therefore,
autious selection of patients, better preventive strategies
or avoiding serious complications, and prompt appropriate
easures against complications seem to be necessary to
mprove the outcomes of endovascular treatment of
hronic occlusive aortic disease.
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